Jack Meehan
Stock Analyst at Barclays
(3.05)
# 1,221
Out of 5,152 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $275.92 | +5.10% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $118.11 | +5.83% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $315.59 | -8.74% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $8.52 | +287.32% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $128.24 | +153.43% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $13.45 | +41.26% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $203.98 | -51.47% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $110.60 | +62.75% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $5.13 | +94.93% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $178.50 | -7.00% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $75.75 | -43.23% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $181.32 | -15.07% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $279.03 | +54.11% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $281.95 | +52.51% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $21.41 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $38.50 | +24.68% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,261.21 | -46.08% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $73.12 | -58.97% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $518.84 | -42.18% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $0.85 | +4,603.67% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $275.92
Upside: +5.10%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $118.11
Upside: +5.83%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $315.59
Upside: -8.74%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $8.52
Upside: +287.32%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $128.24
Upside: +153.43%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $13.45
Upside: +41.26%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $203.98
Upside: -51.47%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $110.60
Upside: +62.75%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $5.13
Upside: +94.93%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $178.50
Upside: -7.00%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $75.75
Upside: -43.23%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $181.32
Upside: -15.07%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $279.03
Upside: +54.11%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $281.95
Upside: +52.51%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $21.41
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $38.50
Upside: +24.68%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,261.21
Upside: -46.08%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $73.12
Upside: -58.97%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $518.84
Upside: -42.18%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $0.85
Upside: +4,603.67%